Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stulln plus sodium hyaluronate eye drops for dry eye disease
ChiCTR2400093427Phase 4Completed
- Sponsor
- Beijing Tongren Hospital
- Start
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Stulln and sodium hyaluronate in dry eye syndrome (DED) (3 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: ocular surface disease index, tear break up time and 2 more. Started Dec 2024; status: completed.
02
Drugs
Stullnsodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2400093427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093427.